Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...

The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal ...

The test potentially makes it easier to find and treat patients with the memory-robbing disease. Read more at ...

Michelle Tarver, of the FDA's Center for Devices and Radiological Health, said: "Today's clearance is an important step for ...

The Global Alzheimer's Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose ...

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

applauds the FDA's clearance of the first blood test to diagnose Alzheimer’s disease. Fujirebio’s Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio invitro diagnostic (IVD) represents the first ...

A blood test that detects early signs of Alzheimer's could be on the NHS in 5 years but with a lack of treatments, would you want to know?

FDA officials have warned the American public to not eat, sell or serve cucumbers grown and distributed by two Florida ...